[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
[2] |
De Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients [J]. Ann Surg, 2009, 250(3): 440-448.
|
[3] |
Lin SH, Raju GS, Huff C, et al. The somatic mutation landscape of premalignant colorectal adenoma [J]. Gut, 2018, 67(7): 1299-1305.
|
[4] |
Ling C, Wang L, Wang Z, et al. A pathway-centric survey of somatic mutations in chinese patients with colorectal carcinomas [J]. PloS One, 2015, 10(1): e0116753.
|
[5] |
Karagkounis G, Torbenson MS, Daniel HD, et al. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases [J]. Cancer, 2013, 119(23): 4137-4144.
|
[6] |
Russo AL, Borger DR, Szymonifka J, et al. Mutational analysis and clinical correlation of metastatic colorectal cancer [J]. Cancer, 2014, 120(10): 1482-1490.
|
[7] |
Tran B, Kopetz S, Tie J, et al. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer [J]. Cancer, 2011, 117(20): 4623-4632.
|
[8] |
Tie J, Lipton L, Desai J, et al. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer [J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 2011, 17(5): 1122-1130.
|
[9] |
Payandeh M, Sadeghi M, Sadeghi E. The report of KRAS mutation and NRAS wild type in a patient with thyroid metastasis from colon cancer: a rare case report [J]. Iran J Pathol, 2016, 11(1): 71-75.
|
[10] |
Yaeger R, Cowell E, Chou JF, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer[J]. Cancer, 2015, 121(8): 1195-1203.
|
[11] |
Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer [J]. Nucleic Acids Research, 2011, 39(Database issue): 945-950.
|
[12] |
Liu X, Wang J, Chen L. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer [J]. Cancer Letters, 2013, 340(2): 270-276.
|
[13] |
Zhang D, Li Z, Xu X, et al. Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome [J]. Carcinogenesis, 2017, 38(11): 1057-1062.
|
[14] |
Arturo LB, Jensen CE, Stuti S, et al. KDR Mutation as a novel predictive biomarker of exceptional response to regorafenib in metastatic colorectal cancer [J]. Cureus, 2016, 8(2): e478.
|
[15] |
Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer [J]. Biochemical & Biophysical Research Communications, 2014, 455(1-2): 43-57.
|